Skip to content

NEOGENOMICS INC

NEO

CIK 0001077183 · Services-Testing Laboratories · Nasdaq

  • AMERICAN COMMUNICATIONS ENTERPRISES INC (until 2002-02-05)
← back to feed
Revenue (TTM)
$250.86M
Q1 Apr 2026
Net Income (TTM)
−$115.25M
−37.2% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$0.21
Q1 Apr 2026
Gross Margin
124.3%
Q1 Apr 2026
Operating Margin
-48.1%
Q1 Apr 2026
Net Margin
-45.9%
Q1 Apr 2026
Free Cash Flow (TTM)
−$97.08M
Q1 Apr 2026
Cash
$146.14M
Q1 Apr 2026
Total Debt
$341.86M
Q1 Apr 2026
Shares Outstanding
130.21M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings